News

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Two clinical trials show the injection is nearly 100% effective at stopping new HIV infections. The vaccine is marketed under ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
The Food and Drug Administration has approved a new injectable drug that can help prevent HIV. Dr. Amesh Adalja, a senior ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Individuals at risk for sexually-acquired HIV have a new injectable option for preexposure prophylaxis with the US Food and Drug Administration’s (FDA’s) approval of lenacapavir, according to a press ...